The circadian rhythm as a lentiviral vector restriction factor
昼夜节律作为慢病毒载体的限制因素
基本信息
- 批准号:10675626
- 负责人:
- 金额:$ 72.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:ARNTL geneAcuteAffectAttentionBehaviorBehavioralBiodistributionBiological ProcessBlood PressureBreedingCell NucleusCellsCharacteristicsCircadian DysregulationCircadian RhythmsClock proteinCollectionCore ProteinCryingCuesCultured CellsCytoplasmDNA RepairDarknessDataDexamethasoneDrug usageEatingEpidemicEtiologyEukaryotic CellExhibitsExposure toFeedbackGene DeliveryGene ExpressionGene TargetingGenesGenetic TranscriptionGenetic VariationGoalsHepaticHigh PrevalenceHormonalHost resistanceHumanHypothalamic structureIn VitroInbred C3H MiceInfectionInflammationInvadedLaboratoriesLentivirus VectorLightMalignant NeoplasmsMediatingMelatoninMelatonin ReceptorsMetabolicMetabolic DiseasesMetabolic PathwayMolecularMotor ActivityMouse StrainsMusNeurodegenerative DisordersNeuronsNeurosecretory SystemsOrganOrphanOutputPathologyPathway interactionsPatternPeripheralPhenotypePhosphorylationPhysiologicalPhysiological ProcessesProductionProteinsProtocols documentationReceptor GeneRepressionRetinaRetinoidsSignal TransductionSimplexvirusSleepSocietiesSubstance abuse problemSympathetic Nervous SystemTemperatureTestingTimeTranscriptional ActivationTranslatingTranslationsUntranslated RNAViralViral VectorVirus DiseasesWorkaddictionantagonistarmcircadiancircadian pacemakerdrug addictgene therapygenetic associationgenomic locushormone regulationimmune functionimprovedin vivoknockout genelight entrainmentmouse modelmutantopioid withdrawalparacrinepathogenpermissivenesssleep patternsuprachiasmatic nucleustransduction efficiencyvector
项目摘要
Abstract:
Circadian rhythm (CR) defines the daily oscillation in gene expression that controls major physiologic pathways
in eukaryotic cells in vivo and in vitro. These biological processes include DNA repair activity, innate and adaptive
immune functions, inflammation, and metabolic pathways. CRs are premised on autonomous peripheral
oscillatory cores, which exist in most organs as well as in cultured cells. In vivo, a central master clock located
in the suprachiasmatic nucleus (SCN) synchronizes the peripheral oscillatory cores via the sympathetic nervous
system and neuroendocrine agents such as melatonin (Mel). Peripheral organs are also entrained by various
metabolic/hormonal and physical inputs (e.g. Dexamethasone, food intake, temperature). However, only the
master SCN core receives light inputs via the retinal hypothalamic tract. All oscillatory cores are based on similar
positive/negative transcriptional/translational feedback loops. Recent studies demonstrated major CR effects on
the course of viral infections in murine models. Altering the time of viral application and knocking out genes
encoding oscillatory core proteins enhanced viral infection by up to 10-fold. To date, CR effects on the efficacy
of Lentiviral vector (LVV) transduction have not been studied. We hypothesize that the CR is a high-level
restriction factor to viral-vector transduction. We propose three specific aims to test this hypothesis. In aim 1, we
will characterize the effects of normal and disrupted CR behavior on hepatic transduction efficiency by LVVs.
We will employ three mouse strains showing distinct circadian behavior and melatonin (Mel) production, including
C3H(Mel+), C57B6 (Mel-), and BMAL1 (oscillatory core protein)-deficient mice. The effects of time of vector
administration, and exposure to either Mel or the Mel- receptor antagonist on hepatic transduction will be
determined. The effects of altered CR behavior patterns on vector transduction will be determined a) following
CR disruption by an acute opioid withdrawal protocol in C57B6 and C3H mice, and b) by gene delivery to naïve
C57B6 and C3H mice following disruption of the normal day-sleep time period. In aim 2, We will test the
hypothesis that normal and disrupted CRs affect LVV transduction efficiency in human and mouse cells in vitro.
Specifically, we will quantify the effects of dexamethasone entrainment on LVV transduction of human and
mouse cells comprising either normal or mutant BMAL1 gene. In aim 3, We will employ an F2 cross between
the CC036 and CC057 mouse strains to determine the existence of a genetic association between the efficiency
of LVV mediated hepatic gene delivery and CR patterns and will identify genetic loci contributing to the above
host and LVV characteristics.
摘要:
昼夜节律(CR)定义了控制主要生理途径的基因表达的每日振荡
在真核细胞体内和体外。这些生物过程包括DNA修复活动,先天和适应性
免疫功能、炎症和代谢途径。CR在自主外围设备上安装
振荡核心,存在于大多数器官以及培养细胞中。在体内,中央主时钟位于
在视交叉上核(SCN),通过交感神经支配周围振荡核团
系统和神经内分泌剂,如褪黑激素(Mel)。外周器官也被各种
代谢/激素和物理输入(例如地塞米松、食物摄入、温度)。但只有
主SCN核心通过视网膜下丘脑束接收光输入。所有振荡核心都基于类似的
正/负转录/翻译反馈环。最近的研究表明,CR对
病毒感染在小鼠模型中的过程。改变病毒应用的时间并敲除基因
编码振荡核心蛋白增强病毒感染高达10倍。迄今为止,CR对疗效的影响
慢病毒载体(LVV)转导的研究。我们假设CR是高水平的
病毒载体转导的限制因素。我们提出了三个具体目标来检验这一假设。在目标1中,我们
将表征正常和破坏的CR行为对LVV肝转导效率的影响。
我们将采用三种小鼠品系,显示出不同的昼夜节律行为和褪黑激素(Mel)的生产,包括
C3 H(Mel+)、C57 B6(Mel-)和BMAL 1(振荡核心蛋白)缺陷型小鼠。矢量时间的影响
施用,并且暴露于Mel或Mel受体拮抗剂对肝转导的影响将是有利的。
测定改变的CR行为模式对载体转导的影响将被确定a)以下
在C57 B6和C3 H小鼠中通过急性阿片样物质戒断方案的CR破坏,和B)通过基因递送至未处理的小鼠,
C57 B6和C3 H小鼠在正常白天睡眠时间段被破坏后。在目标2中,我们将测试
假设正常和破坏的CR影响体外人和小鼠细胞中LVV转导效率。
具体地,我们将量化地塞米松夹带对人和人的LVV转导的影响。
包含正常或突变BMAL 1基因的小鼠细胞。在目标3中,我们将使用F2杂交,
确定CC 036和CC 057小鼠品系之间存在遗传关联的效率
LVV介导的肝脏基因传递和CR模式,并将确定有助于上述的遗传位点
主机和LVV特性。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Structural, functional, and immunogenicity implications of F9 gene recoding.
- DOI:10.1182/bloodadvances.2022007094
- 发表时间:2022-07-12
- 期刊:
- 影响因子:7.5
- 作者:Katneni, Upendra K.;Alexaki, Aikaterini;Hunt, Ryan C.;Hamasaki-Katagiri, Nobuko;Hettiarachchi, Gaya K.;Kames, Jacob M.;McGill, Joseph R.;Holcomb, David D.;Athey, John C.;Lin, Brian;Parunov, Leonid A.;Kafri, Tal;Lu, Qi;Peters, Robert;V. Ovanesov, Mikhail;Freedberg, Daron I.;Bar, Haim;Komar, Anton A.;Sauna, Zuben E.;Kimchi-Sarfaty, Chava
- 通讯作者:Kimchi-Sarfaty, Chava
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAL KAFRI其他文献
TAL KAFRI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAL KAFRI', 18)}}的其他基金
The circadian rhythm as a lentiviral vector restriction factor
昼夜节律作为慢病毒载体的限制因素
- 批准号:
10475046 - 财政年份:2020
- 资助金额:
$ 72.26万 - 项目类别:
The circadian rhythm as a lentiviral vector restriction factor
昼夜节律作为慢病毒载体的限制因素
- 批准号:
10238748 - 财政年份:2020
- 资助金额:
$ 72.26万 - 项目类别:
Lentiviral Vector-Based Gene Therapy and The Host Genetic Background
基于慢病毒载体的基因治疗和宿主遗传背景
- 批准号:
9302512 - 财政年份:2015
- 资助金额:
$ 72.26万 - 项目类别:
Episomal lenti vector for a humanized hemophilia mouse
人源化血友病小鼠的游离慢病毒载体
- 批准号:
7992516 - 财政年份:2010
- 资助金额:
$ 72.26万 - 项目类别:
Novel Viral Vector Delivery Efficient ShRNA Expression
新型病毒载体传递高效 ShRNA 表达
- 批准号:
7171739 - 财政年份:2006
- 资助金额:
$ 72.26万 - 项目类别:
Novel Viral Vector Delivery for Efficient ShRNA Expression
用于高效 ShRNA 表达的新型病毒载体递送
- 批准号:
7295732 - 财政年份:2006
- 资助金额:
$ 72.26万 - 项目类别:
LENTIVIRAL VECTOR BASED GENE THERAPY FOR LIVER DISEASES
基于慢病毒载体的肝病基因治疗
- 批准号:
6517838 - 财政年份:2001
- 资助金额:
$ 72.26万 - 项目类别:
LENTIVIRAL VECTOR BASED GENE THERAPY FOR LIVER DISEASES
基于慢病毒载体的肝病基因治疗
- 批准号:
6846380 - 财政年份:2001
- 资助金额:
$ 72.26万 - 项目类别:
Episomal lenti vector for a humanized hemophilia mouse
人源化血友病小鼠的游离慢病毒载体
- 批准号:
7663777 - 财政年份:2001
- 资助金额:
$ 72.26万 - 项目类别:
Episomal lenti vector for a humanized hemophilia mouse
人源化血友病小鼠的游离慢病毒载体
- 批准号:
7263818 - 财政年份:2001
- 资助金额:
$ 72.26万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 72.26万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 72.26万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 72.26万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 72.26万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 72.26万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 72.26万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 72.26万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 72.26万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 72.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 72.26万 - 项目类别:
Standard Grant














{{item.name}}会员




